Rua Bioscience

Rua Bioscience Current Liabilities

The Current Liabilities of Rua Bioscience (RUA.NZ) as of Oct 18, 2026 is 1.85 M NZD. In the previous year, Current Liabilities was 874,000.00 NZD — a change of 112.01% (higher).

Current Liabilities

1.85 MNZD

YoY

112.01%

Last updated:

Current Liabilities of Rua Bioscience is 2025 1.85 M NZD. Current Liabilities of Rua Bioscience was 2024 874,000.00 NZD. It decreases by 112.01% higher compared to the previous year.

The Rua Bioscience Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
469,800.00 NZD
Jan 1, 2020
998,600.00 NZD
Jan 1, 2021
1.18 M NZD
Jan 1, 2022
4.86 M NZD
Jan 1, 2023
762,400.00 NZD
Jan 1, 2024
874,000.00 NZD
Jan 1, 2025
1.85 M NZD
The Rua Bioscience Current Liabilities history
YEARCurrent LiabilitiesYoY
1.85 MNZD+112.01%
874,000.00NZD+14.64%
762,400.00NZD-84.31%
4.86 MNZD+313.40%
1.18 MNZD+17.70%
998,600.00NZD+112.56%
469,800.00NZD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rua Bioscience Stock analysis

What does Rua Bioscience do? Rua Bioscience Ltd, trading as RUA.NZ, is a pharmaceutical company headquartered in Gisborne, New Zealand. The company operates in the Health Care sector, specifically within Pharmaceuticals. It conducts research and development, and engages in pharmaceutical distribution and marketing. Rua Bioscience focuses on breeding, cultivating, manufacturing, and supplying medicinal cannabis products. The firm operates through one segment, offering research and development services and pharmaceutical products in Germany and New Zealand. It maintains a full research laboratory in Gisborne for cannabinoid testing, microscopic analysis, moisture analysis, sample preparation, extraction, solvent removal, viscosity measurements, and impurity testing. The company completed its IPO on October 22, 2020. Rua Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rua Bioscience stock

Current Liabilities of Rua Bioscience is 1.85 M NZD in 2025.

Current Liabilities of Rua Bioscience changed from 874,000.00 NZD to 1.85 M NZD, representing a 112.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Rua Bioscience since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's NZD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Rua Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Rua Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Rua Bioscience